EODData

ASX, PER: Percheron Therapeutics Ltd.

25 Sep 2026
LAST:

0.0040

CHANGE:
 0.00
OPEN:
0.0050
HIGH:
0.0050
ASK:
0.0110
VOLUME:
3.28M
CHG(%):
20.00
PREV:
0.0050
LOW:
0.0040
BID:
0.0100
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
25 Sep 260.00500.00500.00400.00403.28M
24 Sep 260.00500.00500.00500.00500
23 Sep 260.00400.00500.00400.00501.11M
22 Sep 260.00400.00400.00400.00404.2K
21 Sep 260.00400.00450.00400.00451.91M
18 Sep 260.00450.00450.00400.0040172.7K
17 Sep 260.00400.00400.00400.00400
16 Sep 260.00400.00400.00400.00403.3K
15 Sep 260.00450.00450.00450.0045275.0K
14 Sep 260.00450.00450.00450.00450

PROFILE

Name:Percheron Therapeutics Ltd.
About:Percheron Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia. The company's lead asset is ATL1102, an antisense oligonucleotide inhibitor of CD49d, which is in Phase IIb clinical trial for the treatment of Duchenne muscular dystrophy, multiple sclerosis, asthma, and other inflammatory indications. It also develops HMBD-002, a recombinant humanised monoclonal IgG4 antibody, which completed Phase I clinical trial to targer v-domain immunoglobulin suppressor of T-cell activation and cancer cells. The company was formerly known as Antisense Therapeutics Limited and changed its name to Percheron Therapeutics Limited in December 2023. Percheron Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.
Sector:Healthcare
Address:Collins Place, Melbourne, VIC, Australia, 3000
Website:https://percherontx.com
ISIN:AU000000ANP4
FIGI:BBG000BCF0F7

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-0.35 
Forward P/E:-1.06 
PEG Ratio:-1.06 
Price to Sales:9.02 
Price to Book:0.83 
Operating Margin:-2.23 
Return on Assets:-0.29 
Return on Equity:-0.55 
EPS Ratio:-0.01 
Revenue:843.6K 
Shares:1.522B 
Market Cap:6.09M 

TECHNICAL INDICATORS

MA5:0.0012.5%
MA10:0.0010.0%
MA20:0.0015.0%
MA50:0.005.0%
MA100:0.002.5%
MA200:0.0135.0%
RSI14:33.33 
WPR14:-100.00 
ATR:0.00 
Week High:0.0125.0%
Week Low:0.000.0%
Month High:0.0150.0%
Month Low:0.0035.0%
Year High:0.01175.0%
Year Low:0.00100.0%
Volatility:103.89 

RECENT SPLITS

Date Ratio
05 Nov 20131-10